{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:41:07Z","timestamp":1772498467864,"version":"3.50.1"},"reference-count":62,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>The growing incidence and prevalence of civilization diseases is prompting national and transnational entities to seek instruments that would reverse epidemiological trends. Not without significance is the need to design such solutions that are going to provide an improved relation between the costs incurred to maintain health or recovery and the profit for citizens of continuing to function in good health. In its strategic documents, the European Union indicates the most important development goals in each financial perspective and the tools necessary to achieve them. In the Europe 2020 strategy, a cohesion policy was indicated as an important tool for the implementation of development goals, focusing on supporting activities leading to the equalisation of economic and social conditions in all regions of EU countries. The implementation of one of the three basic priorities of the Europe 2020 strategy, which is inclusive growth\u2014supporting an economy with a high level of employment and ensuring social and territorial cohesion\u2014assumes, among others, that in 2020, the population at risk of poverty and social exclusion will decrease by 20 million and that the employment rate in the EU will increase to 75%. Meeting the objectives will not be possible without a holistic coordinated approach to healthcare at the national and regional level in accordance with the principle of \u201chealth in all policies\u201d. It also requires the involvement of various sources of financing, including structural funds. The EU\u2019s prioritisation of the problems related to ensuring decent conditions for achieving health resulted in the mobilisation of structural funds for actions taken in the healthcare sector. Of particular importance are those actions which are taken to prevent, alleviate, and prevent oncological diseases. An additional contribution to undertaking actions aimed at preventing oncological diseases are the high and often neglected social costs incurred by societies. The goal of the article was to identify and evaluate actions taken in this area in Poland. It was achieved by analysing the literature on the subject and statistical data, and conducting induction based on the above-mentioned sources.<\/jats:p>","DOI":"10.3390\/ijerph17082837","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T04:49:38Z","timestamp":1587444578000},"page":"2837","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oncological Diseases and Social Costs Considerations on Undertaken Health Policy Interventions"],"prefix":"10.3390","volume":"17","author":[{"given":"Tomasz","family":"Holecki","sequence":"first","affiliation":[{"name":"Department of Health Economics and Management, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5063-9238","authenticated-orcid":false,"given":"Maria","family":"W\u0119grzyn","sequence":"additional","affiliation":[{"name":"Department of Finances, Wroclaw University of Economics and Business, 53-345 Wroc\u0142aw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldona","family":"Fr\u0105czkiewicz-Wronka","sequence":"additional","affiliation":[{"name":"Department of Public Management, University of Economic in Katowice, 40-287 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Sobczyk","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Management, Faculty of Health Sciences in Bytom, Medical University of Silesia in Katowice, 41-902 Bytom, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/258724","article-title":"Investment in Human Capital, a Theoretical Analisys","volume":"70","author":"Becker","year":"1962","journal-title":"J. Political Econ."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"World Bank (1993). World Development Report 1993: Investing in Health, Oxford University Press.","DOI":"10.1596\/978-0-1952-0890-0"},{"key":"ref_3","unstructured":"Zamora, J. (2000). Investment in Health and Economic Growth: A Perspective from Latin America and the Caribbean 2000, Pan American Health Organization, Division of Health and Human Development. Available online: http:\/\/www.paho.org\/English\/HDP\/HDR\/ACHR-00-08.pdf."},{"key":"ref_4","unstructured":"Nojszewska, E. (2018). Economic losses and costs of treatment of selected eight cancers in the Lower Silesian Voivodship in 2014\u20132016\u2014Conclusions for Health Policy; Report of the Polish Cancer Society [in Polish:] Straty Ekonomiczne i Koszty Leczenia Wybranych O\u015bmiu Nowotwor\u00f3w w Wojew\u00f3dztwie Dolno\u015bl\u0105skim w Latach 2014-2016\u2014Wnioski dla Polityki Zdrowotnej; Raport Polskiego Towarzystwa Onkologicznego, Polskie Towarzystwo Onkologiczne."},{"key":"ref_5","first-page":"151","article-title":"Burden of cancer in the Eastern Mediterranean Region, 2005\u20132015: Findings from the Global Burden of Disease 2015 Study","volume":"63","author":"Alsharif","year":"2017","journal-title":"Int. J. Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the global burden of disease study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_7","unstructured":"(2019, December 10). World Cancer Research Fund International, American Institute for Cancer Research. Available online: https:\/\/www.wcrf.org\/dietandcancer\/cancer-trends."},{"key":"ref_8","unstructured":"(2019, December 12). Global Cancer Observatory, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.fr\/."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Ga\u0144czak, M., Miazgowski, T., Ko\u017cybska, M., Kotwas, A., Korze\u0144, M., Rudnicki, B., Nogal, T., Andrei, C.L., Ausloos, M., and Banach, M. (2020). Changes in disease burden in Poland between 1990\u20132017 in comparison with other Central European countries: A systematic analysis for the Global Burden of Disease Study 2017. PLoS ONE, 15, Available online: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0226766.","DOI":"10.1371\/journal.pone.0226766"},{"key":"ref_10","unstructured":"Samuelson, P.A., and Nordhaus, W.D. Economics, McGraw-Hill Book Company."},{"key":"ref_11","unstructured":"Begg, D., Fischer, S., and Dornbusch, R. (1984). Economics, McGraw-Hill Book Company."},{"key":"ref_12","unstructured":"Kaplan, R.S., and Cooper, R. (1998). Cost & Effect: Using Integrated Cost Systems to Drive Profitability and Performance, Harvard Business Press."},{"key":"ref_13","first-page":"162","article-title":"Cost accounting and cost management. Relationship considerations [in Polish:] Rachunek koszt\u00f3w a zarz\u0105dzanie kosztami. Rozwa\u017cania o relacjach","volume":"245","author":"Nowak","year":"2015","journal-title":"Studia Ekonomiczne"},{"key":"ref_14","unstructured":"Kapp, K.W. (1978). The Social Costs of Business Enterprise, Russell Press Ltd."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2165\/00019053-199304060-00006","article-title":"Indirect Costs in Economic Studies","volume":"4","author":"Koopmanschap","year":"1993","journal-title":"Pharmaco Econ."},{"key":"ref_16","unstructured":"Caff\u00e8, F. (1999). Lezioni di Politica Economica, Universale Bollati Boringhieri."},{"key":"ref_17","first-page":"7","article-title":"The Social Cost Concepts of K. William Kapp and Karl Polanyi","volume":"23","author":"Swaney","year":"1989","journal-title":"J. Econ."},{"key":"ref_18","first-page":"109","article-title":"Social Costs of Economic Growth","volume":"20","author":"Leipert","year":"1986","journal-title":"J. Econ."},{"key":"ref_19","unstructured":"Acocella, N. (1994). Fondamenti di Politica Economica, La Nuova Scientifica."},{"key":"ref_20","unstructured":"(2019, December 10). Encyclopedia Powszechna. Available online: https:\/\/encyklopedia.pwn.pl\/encyklopedia\/ekonomiczna.html."},{"key":"ref_21","unstructured":"Milewski, R., and Kwiatkowski, E. (2018). Fundamentals of Economics [in Polish:] Podstawy Ekonomii, PWN Scientific Publishing House."},{"key":"ref_22","unstructured":"Nojszewska, E. (2010). Fundamentals of Economics [in Polish:] Podstawy Ekonomii, Wydawnictwo Naukowe PWN."},{"key":"ref_23","unstructured":"Edejer, T. (2003). Tan-Torres, Making Choices in Health: WHO Guide to Cost-effectiveness Analysis, World Health Organization."},{"key":"ref_24","unstructured":"Ruszkowski, J., and Le\u015bniowska, J. (2010). Real, economic costs of illness in Poland, Studies and Materials of the Polish Knowledge Management Association [in Polish:] Rzeczywiste, ekonomiczne koszty choroby w Polsce, Studia i Materia\u0142y Polskiego Stowarzyszenia Zarz\u0105dzania Wiedz\u0105."},{"key":"ref_25","unstructured":"Nowakowska, E. (2018). Pharmacoeconomics in the management of health care resources [in Polish:] Farmakoekonomika w zarz\u0105dzaniu zasobami ochrony zdrowia, Wolters Kluwer."},{"key":"ref_26","unstructured":"Getzen, T.E. (1997). Health Economics: Fundamentals and Flow of Fonds, John Wiley @Sons."},{"key":"ref_27","unstructured":"(2009). Public Health Economics, Department of Health Systems Financing Health Systems and Services World Health Organization, WHO."},{"key":"ref_28","unstructured":"WHO (2009). Guide to Identifying the Economic Consequences of Disease and Injury, Department of Health Systems Financing Health Systems and Services, World Health Organization."},{"key":"ref_29","unstructured":"Raport, E.Y. (2013). Methodology of Measuring Indirect Costs in the Polish Health Care System [in Polish:] Metodyka Pomiaru Koszt\u00f3w Po\u015brednich w Polskim Systemie Ochrony Zdrowia, Program Sprawne Pa\u0144stwo."},{"key":"ref_30","unstructured":"Czajkowski, Z. (2012). Human Capital - Concept and Measures [in Polish:] Kapita\u0142 Ludzki\u2013Poj\u0119cie i Miary. Prace i Materia\u0142y Instytutu Gospodarki \u015awiatowej, Szko\u0142a G\u0142\u00f3wna Handlowa 312."},{"key":"ref_31","unstructured":"Dublin, L.I., and Lotka, A.J. (1977). The Money Value of a Man, Amo Press."},{"key":"ref_32","first-page":"163","article-title":"Indirect costs in health technology assessment [in Polish:] Koszty po\u015brednie w ocenie technologii medycznych","volume":"XXVIII","author":"Jakubczyk","year":"2010","journal-title":"Pol. Merk. Lek."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Jakovljevic, M., Fernandes, P.O., Teixeira, J.P., Rancic, N., Timofeyev, Y., and Reshetnikov, V. (2019). Underlying differences in health spending within the World Health Organisation Europe Region\u2014Comparing EU15, EU post-2004, CIS, EU candidate, and CARINFONET countries. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173043"},{"key":"ref_34","first-page":"101","article-title":"Cost analysis (direct and indirect) related to multiple sclerosis in Poland [in Polish:] Analiza koszt\u00f3w (bezpo\u015brednich i po\u015brednich) zwi\u0105zanych ze stwardnieniem rozsianym w Polsce","volume":"1","author":"Kawalec","year":"2016","journal-title":"Polski Przegl\u0105d Nauk o Zdrowiu Pozna\u0144"},{"key":"ref_35","unstructured":"Grzyba\u0142a, P., Miku\u0142owska, M., Proga, K., Falkiewicz, B., and Kie\u0142czewski, T. (2018). The Direct and Indirect Costs Incurred by Patients with Crohn\u2019s Disease [in Polish:] Koszty Bezpo\u015brednie i Po\u015brednie Ponoszone Przez Pacjent\u00f3w z Chorob\u0105 Le\u015bniowskiego-Crohna, Raport, PEX PharmaSequence Sp. z o.o."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1586\/14737140.2015.1059280","article-title":"Five-year survival and costs of care in metastatic colorectal cancer: Conventional versus monoclonal antibody-based treatment protocols","volume":"15","author":"Kovacevic","year":"2015","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_37","first-page":"1111","article-title":"Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin\u2019s lymphoma","volume":"19","author":"Jakovljevic","year":"2014","journal-title":"J. BUON"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3111\/13696998.2014.971162","article-title":"Radiation therapy remains the key cost driver of oncology inpatient treatment","volume":"18","author":"Jakovljevic","year":"2015","journal-title":"J. Med Econ."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2298\/VSP1504334K","article-title":"End-of-life costs of medical care for advanced stage cancer patients","volume":"72","author":"Gutzwiller","year":"2015","journal-title":"Vojnosanitetski Pregled"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fpubh.2017.00023","article-title":"Disability, Work absenteeism, sickness Benefits, and cancer in selected european OecD countries\u2014Forecasts to 2020","volume":"5","author":"Jakovljevic","year":"2017","journal-title":"Front. Public Health"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5603\/NJO.2013.0032","article-title":"National cancer strategies: Experiences, structure, good practices [in Polish:] Narodowe strategie zwalczania nowotwor\u00f3w: Do\u015bwiadczenia, struktura, dobre praktyki","volume":"63","author":"Kozierkiewicz","year":"2013","journal-title":"Nowotw. J. Oncol."},{"key":"ref_42","unstructured":"(2019, December 21). Strategy Against Cancer [in Polish:] Strategia Walki z Rakiem. Available online: https:\/\/pto.med.pl\/."},{"key":"ref_43","unstructured":"Regulation of the Minister of Finance of Reports of Public Finance, Health Priorities (2018). Journal of Laws of 2018, item 469. 27 February 2018; [in Polish:] (Rozporz\u0105dzenie Ministra Zdrowia z Dnia 27 Lutego 2018 r. w Sprawie Priorytet\u00f3w Zdrowotnych; Dz.U. 2018 poz. 469). Rozporz\u0105dzenie Ministra Zdrowia z Dnia 27 Lutego 2018 r. w Sprawie Priorytet\u00f3w Zdrowotnych, Dz.U.. poz. 469."},{"key":"ref_44","unstructured":"Ruszkowski, J., and Le\u015bniowska, J. (2010). Real, Economic Costs of Illness in Poland [in Polish:] Rzeczywiste, Ekonomiczne Koszty Choroby w Polsce; Seria: Studia i Materia\u0142y, no 25, Polskie Stowarzyszenie Zarz\u0105dzania."},{"key":"ref_45","unstructured":"Smaga, A., Miku\u0142owska, M., Komorowska, A., and Falkiewicz, B. (2014). Breast Cancer in Poland - Treatment is an Investment; Report from the research project [in Polish:] Rak Piersi w Polsce-Leczenie to Inwestycja, Instytut Zarz\u0105dzania w Ochronie Zdrowia Uczelni \u0141azarskiego. Raport z projektu badawczego."},{"key":"ref_46","unstructured":"(2019, December 21). DiLO green card, Available online: www.pakietonkologiczny.gov.pl."},{"key":"ref_47","first-page":"218","article-title":"Has the reform shortened the real waiting time of cancer patients in Poland? [in Polish:] Czy reforma DILO skr\u00f3ci\u0142a realny czas oczekiwania pacjent\u00f3w chorych na nowotwory z\u0142o\u015bliwe w Polsce?","volume":"2","author":"Osowiecka","year":"2017","journal-title":"Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory"},{"key":"ref_48","unstructured":"(2019, December 21). DiLO green card, Available online: http:\/\/www.nfz.gov.pl\/dla-swiadczeniodawcy\/pakiet-onkologiczny\/."},{"key":"ref_49","unstructured":"(2019, December 21). Internal Materials of the Social Insurance Institution, AP-KOLCE, Available online: https:\/\/dilo.nfz.gov.pl\/ap-kolce\/."},{"key":"ref_50","unstructured":"(2019, December 21). Onkobarometr. Available online: http:\/\/www.korektorzdrowia.pl\/onkobarometr\/."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1470-2045(15)70030-6","article-title":"The oncological package: A new source of concern in Poland\u2019s health system","volume":"16","author":"Holecki","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1108\/09526861111105077","article-title":"Swedish healthcare management practices and quality improvement work: Development trends","volume":"2","author":"Elg","year":"2011","journal-title":"Int. J. Health Care Qual. Assur."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Heurgren, M., \u00c5berg, A., K\u00f6ster, M., and Ljung, R. (2007). Performance indicators in Swedish Health Care. BMC Health Serv. Res., 7.","DOI":"10.1186\/1472-6963-7-S1-A10"},{"key":"ref_54","first-page":"1","article-title":"Sweden: Health system review","volume":"14","author":"Anell","year":"2012","journal-title":"Health Syst. Transit."},{"key":"ref_55","unstructured":"(2019, November 25). Der \u00d6sterreichische Strukturpan Gesundheit\u2014\u00d6SG 2017. Available online: https:\/\/www.sozialministerium.at\/Themen\/Gesundheit\/Gesundheitssystem\/Gesundheitssystem-und-Qualit%C3%A4tssicherung\/Planung-und-spezielle-Versorgungsbereiche\/Der-%C3%96sterreichische-Strukturplan-Gesundheit-%E2%80%93-%C3%96SG-2017.html."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10916-019-1436-9","article-title":"Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model","volume":"43","author":"Haberson","year":"2019","journal-title":"J. Med Syst."},{"key":"ref_57","unstructured":"Wi\u0119ckowska, B. (2018). Maps of Health Needs as a Public Payer Instrument in Rationalizing the Health care System [in Polish:] Mapy Potrzeb Zdrowotnych Jako Instrument P\u0142atnika w Racjonalizowaniu Systemu Ochrony Zdrowia, PWN."},{"key":"ref_58","first-page":"1","article-title":"France: Health system review","volume":"17","author":"Chevreul","year":"2015","journal-title":"Health Syst. Transit."},{"key":"ref_59","first-page":"1","article-title":"Spain: Health system review","volume":"20","author":"Oliva","year":"2018","journal-title":"Health Syst. Transit."},{"key":"ref_60","unstructured":"Ministry of Health (2019, December 09). Funds for health, Available online: https:\/\/www.gov.pl\/web\/zdrowie\/programy-realizowane-przez-ministerstwo-zdrowia."},{"key":"ref_61","unstructured":"(2019, December 09). Funds for health, Available online: http:\/\/zdrowie.gov.pl\/strona-585-programy.html."},{"key":"ref_62","unstructured":"Schwab, K. (2016). The Global Competitiveness Report 2016\u20132017, Word Economic Forum."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/8\/2837\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:45:15Z","timestamp":1760363115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/8\/2837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["ijerph17082837"],"URL":"https:\/\/doi.org\/10.3390\/ijerph17082837","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]}}}